Search Results

You are looking at 1 - 10 of 13 items for :

  • "rifaximin" x
  • Refine by Access: All Content x
Clear All

281 Pimentel, M., Lembo, A., Chey, W. D.: Rifaximin therapy for patients with irritable bowel syndrome without constipation. N. Engl. J. Med., 2011, 364 , 22

Restricted access
Magyar Sebészet
Authors:
Imre Fehérvári
,
Balázs Nemes
,
Dénes Görög
,
Zsuzsa Gerlei
, and
László Kóbori

F Poordad 2010 Rifaximin Treatment in Hepatic Encephalopathy N Eng Med J 362 1071 81

Restricted access

. 2007 357 2057 2066 Latella, G., Scarpignato, C.: Rifaximin in the management of colonic diverticular

Open access

Latella, G., Pimpo, M. T., Sotilli, S. és mtsai: Rifaximin improves symptoms of aquired uncomplicated diverticular disease of the colon. Int. J. Colorectal. Dis., 2003, 18 , 55–62. Sotilli S

Restricted access

. C. és mtsai: A randomized, double-blind placebo-controlled trial of rifaximin to prevent travelers’ diarrhea. Ann. Intern. Med., 2005, 142 , 805–812. Okhuysen P. C. A

Restricted access
Orvosi Hetilap
Authors:
László Gulácsi
,
Adrienne Kertész
,
Irén Kopcsóné Németh
,
János Banai
,
Endre Ludwig
,
Gyula Prinz
,
Péter Reményi
,
Bálint Strbák
,
Edit Zsoldiné Urbán
,
Petra Baji
,
Márta Péntek
, and
Valentin Brodszky

455 Basu, P. P., Dinani, A., Rayapudi, K., et al.: Rifaximin therapy for metronidazole-unresponsive Clostridium difficile infection: a prospective pilot trial. Therap. Adv

Restricted access
Physiology International
Authors:
Enikő Kovács
,
Nicolò Maimeri
,
Filippo Orlando
,
Federica Morselli
,
Ottavia Pallanch
,
Monica Fedrizzi
,
János Gál
, and
Andrea Székely

Patients Intervention Comparator Setting Nb. of centers Nb. of participants Blinding Sharma BC et al. 2013 [ 14 ] Am J Gastroenterol cirrhosis and HE rifaximin + lactulose lactulose alone ICU 1 120 double-blinded Merli M et al., 2016 [ 13 ] Hepatology

Open access
Orvosi Hetilap
Authors:
Valentin Brodszky
,
László Gulácsi
,
Endre Ludwig
,
Gyula Prinz
,
János Banai
,
Péter Reményi
,
Bálint Strbák
,
Adrienne Kertész
,
Irén Kopcsóné Németh
,
Edit Zsoldiné Urbán
,
Petra Baji
, and
Márta Péntek

., Berti, E., Morgando, A., et al.: Treatment of pseudomembranous colitis: a randomized controlled trial with rifaximin vs. vancomycin [Terapia della colite da Clostridium difficile: risultati di uno studio randomizzato aperto rifaximina vs. vancomicina

Restricted access

A vastagbél-diverticulosis veszélyei és kezelése.

Újdonságok a nemzetközi útmutatók tükrében

Potential risks and treatment options for colonic diverticular disease.

Novelties based on international guidelines
Orvosi Hetilap
Authors:
Tamás Bubán
,
Nóra Sipeki
,
Csaba Várvölgyi
, and
Mária Papp

–297. 42 Bianchi M, Festa V, Moretti A, et al. Meta-analysis: long-term therapy with rifaximin in the management of uncomplicated diverticular disease. Aliment Pharmacol Ther. 2011; 33: 902

Open access

A bélflóra patofiziológai jelentősége és szerepe mint terápiás célpont májbetegségekben

The role of gut microbiota in chronic liver diseases, and treatment possibilities

Orvosi Hetilap
Authors:
Krisztina Hagymási
,
Anna Bacsárdi
,
Anna Egresi
,
Evelin Berta
,
Zsolt Tulassay
, and
Gabriella Lengyel

, Sanyal AJ, et al. Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy. PloS ONE 2013; 8: e60042. 44

Open access